Veer Bhavnagri
2020
In 2020, Veer Bhavnagri earned a total compensation of $2.4M as General Counsel at Allogene Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $212,500 |
|---|---|
| Option Awards | $1,211,953 |
| Salary | $425,000 |
| Stock Awards | $537,490 |
| Other | $9,385 |
| Total | $2,396,328 |
Bhavnagri received $1.2M in option awards, accounting for 51% of the total pay in 2020.
Bhavnagri also received $212.5K in non-equity incentive plan, $425K in salary, $537.5K in stock awards and $9.4K in other compensation.
Rankings
In 2020, Veer Bhavnagri's compensation ranked 4,739th out of 13,090 executives tracked by ExecPay. In other words, Bhavnagri earned more than 63.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,739 out of 13,090 | 64th |
Division Manufacturing | 1,927 out of 5,621 | 66th |
Major group Chemicals And Allied Products | 756 out of 2,254 | 67th |
Industry group Drugs | 649 out of 1,954 | 67th |
Industry Biological Products, Except Diagnostic Substances | 152 out of 411 | 63rd |
Source: SEC filing on April 22, 2021.
Bhavnagri's colleagues
We found four more compensation records of executives who worked with Veer Bhavnagri at Allogene Therapeutics in 2020.